Jack W. Singer
2017
In 2017, Jack W. Singer earned a total compensation of $981.2K as Executive Vice President, Chief Scientific Officer, Interim Chief Medical Officer and Global Head of Translational Medicine at CTI BioPharma, a 76% increase compared to previous year.
Compensation breakdown
| Bonus | $120,000 |
|---|---|
| Option Awards | $427,618 |
| Salary | $400,000 |
| Other | $33,600 |
| Total | $981,218 |
Singer received $427.6K in option awards, accounting for 44% of the total pay in 2017.
Singer also received $120K in bonus, $400K in salary and $33.6K in other compensation.
Rankings
In 2017, Jack W. Singer's compensation ranked 9,074th out of 14,666 executives tracked by ExecPay. In other words, Singer earned more than 38.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,074 out of 14,666 | 38th |
Division Manufacturing | 3,474 out of 5,772 | 40th |
Major group Chemicals And Allied Products | 1,190 out of 2,075 | 43rd |
Industry group Drugs | 953 out of 1,731 | 45th |
Industry Pharmaceutical Preparations | 746 out of 1,333 | 44th |
Source: SEC filing on March 30, 2018.
Singer's colleagues
We found six more compensation records of executives who worked with Jack W. Singer at CTI BioPharma in 2017.
2017
Adam Craig
CTI BioPharma
Chief Executive Officer
2017
Bruce Seeley
CTI BioPharma
Chief Operating Officer
2017
David Kirske
CTI BioPharma
Chief Financial Officer
2017
Louis Bianco
CTI BioPharma
Former Executive Vice President, Finance and Administration
2017
Matthew Plunkett
CTI BioPharma
Former Executive Vice President, Chief Business Officer
2017
Richard Love
CTI BioPharma